Bibliographic Details
| Title: |
VTX-2337 is a novel TLR8 agonist that activates NK cells and augments ADCC. |
| Authors: |
Lu H; Tumor Vaccine Group, Center for Translational Medicine in Women's Health, University of Washington, Seattle, Washington, USA., Dietsch GN, Matthews MA, Yang Y, Ghanekar S, Inokuma M, Suni M, Maino VC, Henderson KE, Howbert JJ, Disis ML, Hershberg RM |
| Source: |
Clinical cancer research : an official journal of the American Association for Cancer Research [Clin Cancer Res] 2012 Jan 15; Vol. 18 (2), pp. 499-509. Date of Electronic Publication: 2011 Nov 29. |
| Publication Type: |
Journal Article |
| Journal Info: |
Publisher: American Association for Cancer Research Country of Publication: United States NLM ID: 9502500 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1557-3265 (Electronic) Linking ISSN: 10780432 NLM ISO Abbreviation: Clin Cancer Res Subsets: MEDLINE |
| Database: |
MEDLINE Ultimate |
